Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Multiple Myeloma × Budesonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1 Leukemia, Plasma Cell 1

Interventions

Dexamethasone 2 vactosertib 1 iberdomide 1 fludarabine phosphate 1 daratumumab 1 belantamab mafodotin 1 aldesleukin 1 Specimen Handling 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interleukin-2 1 IL32 protein, human 1 Cyclophosphamide 1 Budesonide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05405387 2025-12-03

IMPACT

University of Utah

Phase 2 Suspended

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡